These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18271494)

  • 21. [Psychomotor retardation in depression assessed by visuomotor tasks. Overview and achievements of ten years' research].
    Pier MP; Hulstijn W; van Hoof JJ; Sabbe BG
    Tijdschr Psychiatr; 2006; 48(2):95-106. PubMed ID: 16958193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different manifestation of depressive disorder in the elderly.
    Shahpesandy H
    Neuro Endocrinol Lett; 2005 Dec; 26(6):691-5. PubMed ID: 16380682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The construct of minor and major depression in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    Am J Psychiatry; 2005 Nov; 162(11):2086-93. PubMed ID: 16263848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of beta-endorphin with specific clinical symptoms of depression.
    Darko DF; Risch SC; Gillin JC; Golshan S
    Am J Psychiatry; 1992 Sep; 149(9):1162-7. PubMed ID: 1503128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms].
    Bonnet A; Bréjard V; Pasquier A; Pedinielli JL
    Encephale; 2012 Jun; 38(3):187-93. PubMed ID: 22726406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do prostate cancer patients suffer more from depressed mood or anhedonia?
    Sharpley CF; Bitsika V; Christie DH
    Psychooncology; 2013 Aug; 22(8):1718-23. PubMed ID: 23019092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
    Sato T; Bottlender R; Kleindienst N; Möller HJ
    J Affect Disord; 2005 Feb; 84(2-3):187-96. PubMed ID: 15708416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach.
    de Coster L; Leentjens AF; Lodder J; Verhey FR
    Int J Geriatr Psychiatry; 2005 Apr; 20(4):358-62. PubMed ID: 15799083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychomotor retardation in elderly depressed patients.
    Pier MP; Hulstijn W; Sabbe BG
    J Affect Disord; 2004 Jul; 81(1):73-7. PubMed ID: 15183603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression.
    Maes M; Meltzer HY; Scharpé S; Cooreman W; Uyttenbroeck W; Suy E; Vandervorst C; Calabrese J; Raus J; Cosyns P
    Psychiatry Res; 1993 Jun; 47(3):229-41. PubMed ID: 8372161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the relationship between plasma neuropeptide-S levels and clinical depression.
    Baykan H; Durmaz O; Baykan O; Sahin Can M; Kara H; Hismiogullari AA; Karlidere T
    Nord J Psychiatry; 2018 May; 72(4):292-295. PubMed ID: 29488437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder.
    Mula M; Pini S; Calugi S; Preve M; Masini M; Giovannini I; Rucci P; Cassano GB
    Compr Psychiatry; 2010; 51(2):187-92. PubMed ID: 20152301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
    Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
    Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features.
    Cubala WJ; Landowski J; Szyszko M; Wielgomas B
    Neuro Endocrinol Lett; 2014; 35(8):741-5. PubMed ID: 25702304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals.
    Lampe IK; Kahn RS; Heeren TJ
    J Geriatr Psychiatry Neurol; 2001; 14(1):11-6. PubMed ID: 11281310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.